Clinical Trial: A Study to Evaluate ALN-2232 in Participants With Obesity

U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07463846) titled 'A Study to Evaluate ALN-2232 in Participants With Obesity' on March 06.

Brief Summary: The purpose of this study is to:

* evaluate the safety, tolerability, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of single ascending doses of ALN-2232 in patients with obesity

* evaluate the safety, tolerability, efficacy, PK, and PD of multiple doses of ALN-2232 in patients with obesity

* evaluate the safety, tolerability, efficacy, PK, and PD of multiple doses of ALN-2232 co-initiated with tirzepatide in patients with obesity

Study Start Date: March 02

Study Type: INTERVENTIONAL

Condition: Obesity

Intervention: DRUG: AL...